COVID–19 Testing Coverage Act of 2021

Hozzl · 2022-12-31T05:36:28Z

Explore the details of House Bill 5432 COVID–19 Testing Coverage Act of 2021 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/31/2022, 5:36 AM

Summary of Bill HR 5432

Bill 117 HR 5432, also known as the COVID-19 Testing Coverage Act of 2021, aims to provide coverage for COVID-19 testing for all individuals in the United States. The bill requires all public and private health insurance plans to cover the cost of COVID-19 testing, including diagnostic tests, antibody tests, and any future tests related to the virus.

Additionally, the bill prohibits insurance companies from imposing any cost-sharing requirements, such as copayments or deductibles, for COVID-19 testing. This ensures that individuals can access testing without facing financial barriers.

Furthermore, the bill includes provisions to ensure that testing is widely available, including funding for community health centers and other healthcare providers to expand testing capacity. It also requires the Department of Health and Human Services to develop a national testing strategy to guide the distribution of tests and resources. Overall, the COVID-19 Testing Coverage Act of 2021 aims to ensure that all individuals in the United States have access to COVID-19 testing without facing financial barriers, in order to control the spread of the virus and protect public health.

Congressional Summary of HR 5432

COVID-19 Testing Coverage Act of 2021

This bill requires private health insurance to cover, without cost sharing, testing to assess the T cell immune response of an individual to COVID-19. This test indicates a recent or prior infection with COVID-19.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5432

Bill HR 5432 is currently in the status of Bill Introduced since September 30, 2021. Bill HR 5432 was introduced during Congress 117 and was introduced to the House on September 30, 2021. Bill HR 5432's most recent activity was Referred to the Subcommittee on Health. as of October 1, 2021

Bipartisan Support of Bill HR 5432

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5432

Primary Policy Focus

Health

Potential Impact Areas

- Cardiovascular and respiratory health

- Emergency medical services and trauma care

- Employee benefits and pensions

- Health care costs and insurance

- Health care coverage and access

- Immunology and vaccination

- Infectious and parasitic diseases

- Medical tests and diagnostic methods

Alternate Title(s) of Bill HR 5432

To amend the Families First Coronavirus Response Act to require group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing.

COVID–19 Testing Coverage Act of 2021